Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2018 | Inhibition of ATR downregulates PD-L1 and sensitizes tumor cells to T cell-mediated killing. | Sun, LL; Yang, RY; Li, CW; Chen, MK; Shao, B; Hsu, JM; Chan, LC; Yang, Y; Hsu, JL; Lai, YJ; Hung, MC | American journal of cancer research 8(7), 1307-1316 | | | |
2016 | Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis | Lin, C; Yang, WE; Lee, WJ; Hua, KT; Hsieh, FK; Hsiao, M; Chen, CC; Cow, JM; Chen, MK; Yang, SF; Chien, MH | Carcinogenesis 37(7), 712-722 | | | |
2017 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Jiao, S; Xia, W; Yamaguchi, H; Wei, Y; Chen, MK; Hsu, JM; Hsu, JL; Yu, WH; Du, Y; Lee, HH; Li, CW ; Chou, CK; Lim, SO; Chang, SS; Litton, J; Arun, B; Hortobagyi, GN; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 23(14), 3711-3720 | | | |
2019 | Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells. | Han, Y; Chen, MK; Wang, HL; Hsu, JL; Li, CW ; Chu, YY; Liu, CX; Nie, L; Chan, LC; Yam, C; Wang, SC; He, GJ; Hortobagyi, GN; Tan, XD; Hung, MC | American journal of cancer research 9(3), 608-618 | | | |